Researchers have identified a simple daily habit that might lower the risk of premature death, especially from heart disease. You won’t need a gym membership.

Findings from a Recent Study

An analysis from the University of East Anglia and Norfolk and Norwich University Hospital found significant benefits from stair climbing.

Participants who climbed stairs had a 39% lower risk of dying from cardiovascular disease and a 24% lower risk of dying from any cause compared to those who did not.

Stair climbers were less likely to encounter severe cardiovascular conditions such as heart attacks, strokes, and heart failure.

Context of Cardiovascular Disease

Cardiovascular disease remains the top cause of death globally, with cases almost doubling from 1990 to 2019, according to Vassilios Vassiliou of UEA’s Norwich Medical School.

Study’s Scope and Insights

After examining nearly 1,900 studies, researchers reviewed data from over 480,000 individuals across nine studies. These participants were healthy or had a history of heart problems, ranging from 35 to 84 years old.

While stair climbing shows an association with lower mortality risk, it doesn’t directly prove that climbing stairs causes longer life.

Benefits of Stair Climbing

Stair climbing is effective. The low-impact exercise moves against gravity, engaging many muscle groups, benefiting both strength and cardiovascular health.

Large study findings suggest that climbing about six flights a day may be most beneficial, though optimal amounts require further study.

General Health Insights

Many adults globally do not meet recommended activity levels. Factors like a sedentary lifestyle, smoking, poor diet, and obesity worsen cardiovascular disease risks.

Stair climbing is a convenient exercise option for those short on time or lacking access to traditional workouts.

Additional Recommendations

Brief periods of physical activity, such as stair climbing, can measurably benefit health.

Researchers advise that stair climbing may not suit everyone, especially those with mobility or joint issues.

The findings have been published in the American Journal of Cardiovascular Drugs.